ALT-801 is under investigation in clinical trial NCT01478074 (ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.